Orion’s milestone in the 2010s

2013: Foreign markets represent two-thirds of Orion’s net sales. Most of its research operations are carried out in Finland, and all of its own production plants are in Finland. Pictured here the plant in Turku.

2014: Generic drugs represent nearly 50% of Orion’s net sales.

2016: Burana, the most trusted painkiller in Finland, turns 30.